Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors
ConditionLiver Tumor
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorXijing Hospital
About this trial
To explore an effective noninvasive method for differential diagnosis of liver tumors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
A total of 200 patients whose pathological diagnoses were confirmed by US-guided liver biopsy or surgery and who underwent preoperative conventional US between January 2018 and November 2025 were enrolled in the study.
Trial design
Design model
Other
Time perspective
Retrospective
Treatments tested in this trial
with chronic liver disease
Diagnostic testpatients with hepatitis B virus，hepatitis C virus, or other chronic liver disease
Treatment groups
200 Participants
are divided into 2 treatment groupsGroup A: with chronic liver disease1 intervention
Group B: without chronic liver disease0 interventions
Trial outcomes
Primary outcomes
1
The differential diagnosis of liver tumors
Multimodal ultrasound is of great value in the differential diagnosis of liver tumors
Time frame
2018.01-2025.12Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov